1. Home
  2. NVCR vs BKD Comparison

NVCR vs BKD Comparison

Compare NVCR & BKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • BKD
  • Stock Information
  • Founded
  • NVCR 2000
  • BKD 2005
  • Country
  • NVCR Switzerland
  • BKD United States
  • Employees
  • NVCR N/A
  • BKD N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • BKD Hospital/Nursing Management
  • Sector
  • NVCR Health Care
  • BKD Health Care
  • Exchange
  • NVCR Nasdaq
  • BKD Nasdaq
  • Market Cap
  • NVCR 1.9B
  • BKD 1.5B
  • IPO Year
  • NVCR 2015
  • BKD 2005
  • Fundamental
  • Price
  • NVCR $19.11
  • BKD $6.51
  • Analyst Decision
  • NVCR Buy
  • BKD Buy
  • Analyst Count
  • NVCR 6
  • BKD 5
  • Target Price
  • NVCR $32.83
  • BKD $7.70
  • AVG Volume (30 Days)
  • NVCR 941.3K
  • BKD 2.7M
  • Earning Date
  • NVCR 07-24-2025
  • BKD 05-06-2025
  • Dividend Yield
  • NVCR N/A
  • BKD N/A
  • EPS Growth
  • NVCR N/A
  • BKD N/A
  • EPS
  • NVCR N/A
  • BKD N/A
  • Revenue
  • NVCR $621,711,000.00
  • BKD $3,015,786,000.00
  • Revenue This Year
  • NVCR $5.56
  • BKD $8.43
  • Revenue Next Year
  • NVCR $9.15
  • BKD N/A
  • P/E Ratio
  • NVCR N/A
  • BKD N/A
  • Revenue Growth
  • NVCR 18.27
  • BKD 4.14
  • 52 Week Low
  • NVCR $14.17
  • BKD $4.45
  • 52 Week High
  • NVCR $34.13
  • BKD $8.12
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 58.46
  • BKD 49.77
  • Support Level
  • NVCR $18.66
  • BKD $6.31
  • Resistance Level
  • NVCR $20.06
  • BKD $6.65
  • Average True Range (ATR)
  • NVCR 0.86
  • BKD 0.19
  • MACD
  • NVCR 0.19
  • BKD -0.06
  • Stochastic Oscillator
  • NVCR 71.98
  • BKD 26.71

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About BKD Brookdale Senior Living Inc.

Brookdale Senior Living Inc operates senior living communities throughout the United States. The company has three reportable segments: Independent Living, Assisted Living and Memory Care, and Continuing Care Retirement Communities (CCRs). The majority of the revenue is generated from the Assisted Living and Memory Care segment, which offers housing and assistance with activities of daily living to its customers. The company generates revenue in the form of Resident Fees, which it receives in exchange for the services provided, and in the form of management fees from certain communities under contract in exchange for the management services provided.

Share on Social Networks: